In vivo muscarinic binding selectivity of (R,S)- and (R,R)-[F-18]-fluoromethyl QNB

被引:13
作者
Kiesewetter, DO
Carson, RE
Jagoda, EM
Endres, CJ
Der, MG
Herscovitch, P
Eckelman, WC
机构
[1] National Institutes of Health, Positron Emission Tomography Dept., Warren G. Magnusen Clinical Center, Bethesda, MD 20892-1180
[2] NIH/CC/ PET, Building 10, Bethesda, MD 20892-1180
关键词
D O I
10.1016/S0968-0896(97)00100-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have developed a multistep radiochemical synthesis of two diastereomers of quinuclidinyl-4-[F-18]-fluoromethylbenzilate ([F-18]-FMeQNB), a high-affinity ligand for muscarinic acetylcholine receptors. Previously, we have shown that the nonradioactive (R,R)-diastereomer displays an eightfold selectivity for M1 over M2 while the nonradioactive (R,S)-diastereomer displays a sevenfold selectivity for M2 over M1 in vitro. This paper reports the results of in vivo comparison studies. In the rat, uptake of (R,S)-[F-18]-FMeQNB was nearly uniform in all brain regions following the concentration of M2 subtype. The uptake was reduced by 36-54% in all brain regions on coinjection with 50 nmol of unlabeled ligand. An injection of (R,S)-[F-18]-FMeQNB followed at 60 min by injection of unlabeled ligand and subsequent sacrifice at 120 min displaced 30-50% of radioactivity in the pens, medulla, and cerebellum, which contain a high proportion of M2 subtype. The most dramatic displacement and inhibition of uptake on coinjection of (R,S)-[F-18]-FMeQNB was observed in the heart. In rhesus monkey, the compound showed prolonged uptake and retention in the brain. In the blood, the parent compound degraded rapidly to a single radiolabeled polar metabolite believed to be fluoride. Within 30 min the parent compound represented less than 5% of the plasma activity. Displacement with (R)-QNB was generally slow, but was more rapid from those tissues which contain a higher proportion of M2 subtype. The results are consistent with the hypothesis that (R,S)-[F-18]-FMeQNB is M2 selective in vivo. On the other hand, (R,R)-[F-18]-FMeQNB showed higher uptake in those brain regions containing a higher concentration of M1 subtype. Uptake in the heart at 60 min was much lower than that observed with the (R,S)-diastereomer. Inhibition of uptake on coinjection with unlabeled (R,S)-FMeQNB is only significant in the heart, thalamus, and pens. Inhibition of uptake on coinjection with unlabeled (R,R)-FMeQNB is quite uniform in all brain regions. Displacement with (R)-QNB shows a more varying amount displaced. These results are consistent with (R,R)-[F-18]-FMeQNB being M1 selective in vivo. Published by Elsevier Science Ltd.
引用
收藏
页码:1555 / 1567
页数:13
相关论文
共 34 条
[1]   COMPARATIVE ALTERATIONS OF NICOTINIC AND MUSCARINIC BINDING-SITES IN ALZHEIMERS AND PARKINSONS DISEASES [J].
AUBERT, I ;
ARAUJO, DM ;
CECYRE, D ;
ROBITAILLE, Y ;
GAUTHIER, S ;
QUIRION, R .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) :529-541
[2]   DESIGN AND SYNTHESIS OF F-18 LABELED NEUROTOXIC ANALOGS OF MPTP [J].
BERRIDGE, MS ;
SAYRE, LM ;
ARORA, PK ;
TERRIS, AH ;
RIACHI, NJ ;
HARIK, SI .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (09) :1284-1290
[3]   Autoradiographic evidence that (R)-3-quinuclidinyl (S)-4-fluoromethylbenzilate ((R,S)-FMeQNB) displays in vivo selectivity for the muscarinic m2 subtype [J].
Boulay, SF ;
Sood, VK ;
Rayeq, MR ;
Zeeberg, BR ;
Eckelman, WC .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (07) :889-896
[4]  
DANNALS RF, 1988, APPL RADIAT ISOTOPES, V39, P291
[5]  
DEGRADO TR, 1994, J NUCL MED, V35, P1398
[6]   MAPPING MUSCARINIC RECEPTORS IN HUMAN AND BABOON BRAIN USING [N-C-11-METHYL]-BENZTROPINE [J].
DEWEY, SL ;
MACGREGOR, RR ;
BRODIE, JD ;
BENDRIEM, B ;
KING, PT ;
VOLKOW, ND ;
SCHLYER, DJ ;
FOWLER, JS ;
WOLF, AP ;
GATLEY, SJ ;
HITZEMANN, R .
SYNAPSE, 1990, 5 (03) :213-223
[7]   PET study of the M(1)-agonists [C-11]xanomeline and [C-11]butylthio-TZTP in monkey and man [J].
Farde, L ;
Suhara, T ;
Halldin, C ;
Nyback, H ;
Nakashima, Y ;
Swahn, CG ;
Karlsson, P ;
Ginovart, N ;
Bymaster, FP ;
Shannon, HE ;
Foged, C ;
Suzdak, PD ;
Sauerberg, P .
DEMENTIA, 1996, 7 (04) :187-195
[8]  
FLYNN DD, 1995, J NEUROCHEM, V64, P1888
[9]   DISTINCT KINETIC BINDING-PROPERTIES OF N-[H-3]-METHYLSCOPOLAMINE AFFORD DIFFERENTIAL LABELING AND LOCALIZATION OF M1, M2, AND M3-MUSCARINIC-RECEPTOR SUBTYPES IN PRIMATE BRAIN [J].
FLYNN, DD ;
MASH, DC .
SYNAPSE, 1993, 14 (04) :283-296
[10]   INVIVO MUSCARINIC CHOLINERGIC RECEPTOR IMAGING IN HUMAN BRAIN WITH [C-11] SCOPOLAMINE AND POSITRON EMISSION TOMOGRAPHY [J].
FREY, KA ;
KOEPPE, RA ;
MULHOLLAND, GK ;
JEWETT, D ;
HICHWA, R ;
EHRENKAUFER, RLE ;
CAREY, JE ;
WIELAND, DM ;
KUHL, DE ;
AGRANOFF, BW .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1992, 12 (01) :147-154